These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24523730)

  • 21. Agonist of PPAR-γ Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1.
    Yang P; Chen S; Zhong G; Kong W; Wang Y
    Int J Med Sci; 2019; 16(12):1631-1641. PubMed ID: 31839751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload.
    Lin H; Shen L; Zhang X; Xie J; Hao H; Zhang Y; Chen Z; Yamamoto H; Liao W; Bin J; Cao S; Huang X; Liao Y
    PLoS One; 2016; 11(6):e0158514. PubMed ID: 27355349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.
    Ismael S; Purushothaman S; Harikrishnan VS; Nair RR
    Mol Cell Biochem; 2015 Aug; 406(1-2):173-82. PubMed ID: 25976666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis.
    Xu J; Racke MK; Drew PD
    J Neurochem; 2007 Dec; 103(5):1801-10. PubMed ID: 17727629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction.
    Olivero-Verbel J; Harkema JR; Roth RA; Ganey PE
    Chem Biol Interact; 2021 Aug; 345():109521. PubMed ID: 34052195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
    Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells.
    Ji Y; Wang Z; Li Z; Liu J
    Cell Physiol Biochem; 2010; 25(6):631-40. PubMed ID: 20511708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
    Li Q; Li ZM; Sun SY; Wang LP; Wang PX; Guo Z; Yang HW; Ye JT; Lu J; Liu PQ
    Acta Pharmacol Sin; 2019 May; 40(5):589-598. PubMed ID: 30030529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver.
    Won TW
    Korean J Hepatobiliary Pancreat Surg; 2013 Aug; 17(3):89-108. PubMed ID: 26155222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.
    Castiglioni L; Pignieri A; Fiaschè M; Giudici M; Crestani M; Mitro N; Abbate M; Zoja C; Rottoli D; Foray C; Fiordaliso F; Guerrini U; Tremoli E; Sironi L; Gelosa P
    J Hypertens; 2018 May; 36(5):1129-1146. PubMed ID: 29278547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload.
    Zhang L; Zhang B; Yu Y; Wang J; Wu J; Su Y; Jiang H; Zou Y; Ge J
    Int Heart J; 2021 Jan; 62(1):162-170. PubMed ID: 33455985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells.
    Killeen ME; Englert JA; Stolz DB; Song M; Han Y; Delude RL; Kellum JA; Fink MP
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1070-9. PubMed ID: 16382025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome Proliferator-Activated Receptor
    Jen HL; Liu PL; Chen YH; Yin WH; Chen JW; Lin SJ
    Mediators Inflamm; 2016; 2016():5609121. PubMed ID: 27807394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Janus face of HMGB1 in heart disease: a necessary update.
    Raucci A; Di Maggio S; Scavello F; D'Ambrosio A; Bianchi ME; Capogrossi MC
    Cell Mol Life Sci; 2019 Jan; 76(2):211-229. PubMed ID: 30306212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.
    De Silva DS; Wilson RM; Hutchinson C; Ip PC; Garcia AG; Lancel S; Ito M; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1983-93. PubMed ID: 19395558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.